Evidence map›Paper›PMID 42534345›Full record

ArticleJournal of patient experience2026

Patient Experiences With Antibody-Drug Conjugates: Bridging Efficacy and Quality of Life in Metastatic Breast Cancer Care.

Martha Carlson, Amy Beumer, Julia Maués, A J Veach, Janice Cowden, Stephanie Walker, Kelly Shanahan, Jo Lynn Collins, Julia Maués

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of patient experience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Martha CarlsonPatient Centered Dosing Initiative, University Park, FL, USA.ORCID https://orcid.org/0009-0008-7994-6443
Amy BeumerPatient Centered Dosing Initiative, University Park, FL, USA.
Julia MauésPatient Centered Dosing Initiative, University Park, FL, USA.
A J VeachPatient Centered Dosing Initiative, University Park, FL, USA.
Janice CowdenPatient Centered Dosing Initiative, University Park, FL, USA.
Stephanie WalkerPatient Centered Dosing Initiative, University Park, FL, USA.
Kelly ShanahanPatient Centered Dosing Initiative, University Park, FL, USA.
Jo Lynn CollinsPatient Centered Dosing Initiative, University Park, FL, USA.
Julia MauésPatient Centered Dosing Initiative, University Park, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

People diagnosed with metastatic breast cancer (MBC) comprise a growing population, with incidence increasing from 5.8 to 7.9 per 100,000 people between 2001 and 2021. Those living with MBC are often the first to receive newly approved breast cancer therapies. Recently, antibody-drug conjugates (ADCs) have become increasingly common across the MBC treatment landscape, yet insufficient practical understanding of dosing and toxicity management remains. In this Patient Perspective, a patient-led effort highlights themes of quality of life for people treated with ADCs, as well as recommendations related to dose finding in clinical trials, toxicity management, and education efforts for healthcare providers and patients.

Indexed as

antibody-drug conjugatecancercommunicationmedical decision makingpatient experiencequality of lifeshared decision makingside effect management

Identifiers

PMID42534345
PMCPMC13420070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.